IMAGING AND READ CRITERIA IN CANCER IMMUNOTHERAPY CLINICAL TRIALS
Immunotherapies are drugs that use the patient’s immune system to treat cancer by boosting the natural defences or by helping the system recognize a cancer cell as foreign.
Immunotherapy is transforming cancer treatment, but it also presents new challenges in how response is measured. In this eBook, we examine the role of imaging in immunotherapy trials, explain key read criteria—including iRECIST—and outline the importance of central review for consistent evaluation.